Showing results (1-10 of 5,436) with videos related to
Sort By:
Pageof 544
British Journal of Urology|August 1, 1989
Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agentsE A Kiely, S R Bloom, G WilliamsScandinavian Journal of Gastroenterology. Supplement|January 1, 1986
Postprandial effects of SMS 201-995 on gut hormones and glucose toleranceG Williams, H Fuessl, M Kraenzlin, et al.Digestion|January 1, 1987
Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in manH S Fuessl, G Carolan, G Williams, et al.Lancet (London, England)|December 5, 1987
Glucagon-like peptide-1 7-36: a physiological incretin in manB Kreymann, G Williams, M A Ghatei, et al.British Journal of Urology|April 1, 1987
Studies on intracavernosal VIP levels during pharmacologically induced penile erectionsE A Kiely, M A Blank, S R Bloom, et al.Acta Endocrinologica. Supplementum|January 1, 1987
Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretionG Williams, J V Anderson, S J Williams, et al.Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1987
Guar sprinkled on food: effect on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetic patientsH S Fuessl, G Williams, T E Adrian, et al.British Medical Journal (Clinical Research Ed.)|May 21, 1983
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonistJ M Allen, J P O'Shea, K Mashiter, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1988
Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitusG Williams, H S Füessl, J M Burrin, et al.British Journal of Urology|October 1, 1984
Experience with an LHRH analogue in the management of relapsed progressive prostatic cancerD Kerle, G Williams, H Ware, et al.Pageof 544